BMJ: Summary of the efficacy of various COVID-19 vaccines
- Breast Cancer: Dual Immunotherapy Achieves 50% Response in TNBC Without Chemotherapy
- More than 39 million people could die from drug-resistant bacteria by 2050?
- What Risks Should Women Over 40 Consider with Emergency Contraception?
- 100% 3-Year Survival in dMMR Colon Cancer with Neoadjuvant Immunotherapy | ESMO 2024
- Why Chemotherapy Remains a Main Treatment Against Cancer Today?
- Prolonged Presence of COVID Antigens Disrupts Brain’s Immune Response
BMJ: Summary of the efficacy of various COVID-19 vaccines
- Shocking! All existing AIDS vaccine developments have failed
- Sanofi Japan Data Breach: 730000 Healthcare Professionals’ Information Exposed
- CT Radiation Exposure Linked to Blood Cancer in Children and Adolescents
- FDA has mandated a top-level black box warning for all marketed CAR-T therapies
- Can people with high blood pressure eat peanuts?
- What is the difference between dopamine and dobutamine?
- How long can the patient live after heart stent surgery?
BMJ: Summary of the efficacy of various COVID-19 vaccines
Recently, BMJ Medicine , a subsidiary of the British Medical Journal, published a review paper titled: Covid-19: virology, variants, and vaccines , outlining the virology, mutants, and vaccines of the new coronavirus.
Since the outbreak of the COVID-19 virus, the WHO has been paying attention to the mutation of the COVID-19 virus.
As of January this year, a total of 5 highly concerned variants (variants of concern) , 2 worthy of attention (variants of interest) , and 3 Variants are being tested.
The table below lists the names of these variants, the spike protein mutations, and when and where they were first discovered.
As of January 24, 2022, a total of 33 COVID-19 vaccines have been approved worldwide and used in 197 countries, of which 10 COVID-19 vaccines have been approved by the World Health Organization (WHO) for emergency use.
As of January 25, 2022, there are 194 vaccines in preclinical development and 140 in clinical development worldwide.
Numerous studies have explored the effectiveness of these approved vaccines, however, from the reported data, the effectiveness of these vaccines varies widely.
This difference may be due to several factors in the study, including the country, time and population size of the study, and the type of SARS-CoV-2 variant that spread during the study period.
These complex factors mean that it is difficult to directly compare the effects of these vaccines.
The table below lists public data on several COVID-19 vaccines that have received emergency approval from the WHO.
They are:
- Pfizer/BioNTech’s mRNA vaccine – BNT162b2,
- Oxford University/AstraZeneca’s adenovirus vector vaccine – ChAdOx1,
- Johnson & Johnson’s adenovirus vector vaccine – Ad26.COV2.S,
- Moderna’s mRNA vaccine – mRNA-1273 ,
- Sinopharm’s inactivated virus medicine – BBIBP-CorV,
- Sinovac’s inactivated virus vaccine – CoronaVac,
- India Bharat Bio’s whole virus inactivated vaccine – Covaxin,
- Novavax’s protein subunit vaccine – NVX -CoV2373.
Reference:
https://bmjmedicine.bmj.com/content/1/1/e000040
BMJ: Summary of the efficacy of various COVID-19 vaccines
(source:internet, reference only)
Disclaimer of medicaltrend.org
Important Note: The information provided is for informational purposes only and should not be considered as medical advice.